Trial intelligence / Profile preview

Ropivacaine ESP Block for Upper Abdominal Surgery

NCT04702685Phase 3Unknown

Sponsor
University Medical Center
Start
Jan 2021
Primary completion
May 2021
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 3 trial of ropivacaine in postoperative pain, sponsored by University Medical Center. Status: unknown.

02

Drugs

ropivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT04702685.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04702685.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call